Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2
August 04, 2021

MINNEAPOLIS, Aug. 4, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC) recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection and characterization of viral strains, particularly for fatal cases in which no previous testing for SARS-CoV-2 was performed.

According to findings published in the March 2021 issue of the Journal of Infectious Disease, SARS-CoV-2 RNA was visualized directly in the autopsied tissues of suspected COVID-19 patients through in situ hybridization (ISH) using the RNAscope technology from Advanced Cell Diagnostics (ACD), a Bio-Techne brand. RNAscope enables detection of RNA transcripts while retaining cellular morphology, allowing researchers to localize SARS-CoV-2 RNA directly in the tissues, including in the hyaline membranes, pneumocytes and macrophages of lung, and epithelial cells of airways.

Using a combination of SARS-CoV-2 tissue RT-PCR, subgenomic RT-PCR and RNAscope, the authors were able to identify cellular targets of viral infection and replication in tissues from fatal COVID-19 patients, which is very important to understand the severe disease outcomes and viral pathogenesis. RNAscope enabled the CDC scientists to demonstrate the location of the virus not only in the respiratory tissues of several cases, but also in the endothelial cells and blood vessel walls of brain stem, leptomeninges, lung, heart, liver, kidney, and pancreas in one case, suggesting that SARS-CoV-2 infection of endothelial cells may play a crucial role in vascular complications.

Based on the results of this and other studies using the RNAscope technology for the detection of SAR-CoV-2, Bio-Techne's Advanced Cell Diagnostics is launching one of the probes used in the study specific for the Spike protein mRNA as an Analyte Specific Reagent (ASR). The SARS-CoV-2 ASR will provide researchers and pathologists with a powerful technology for the detection of SARS-CoV-2 in fixed tissues.

"We are honored that RNAscope aided CDC researchers in the detection of SARS-CoV-2 in the fatal suspected COVID-19 cases without previous testing for SARS-CoV-2 and in advancing the understanding of SARS-CoV-2 pathogenesis," said Kim Kelderman, President of the Diagnostics and Genomics Segment of Bio-Techne. "Over the course of the pandemic, few technologies have been developed for the direct localization of SARS-CoV-2 RNA in fixed tissues, which has led ACD to develop the SARS-CoV-2 ASR and other RNAscope probes. During the pandemic, RNAscope probes have been an essential tool in elucidating the pathology of this devastating virus in over one hundred COVID-19 publications to date."

Reference
Bhatnagar J, Gary J, Reagan-Steiner S, Estetter LB, Tong S, et al. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series. J Infect Dis. 2021 Mar 3;223(5):752-764.

About Bio-Techne Corporation (NASDAQ: TECH)

Contact:   David Clair, Senior Director, Investor Relations & Corporate Development
                    david.clair@bio-techne.com
                    612-656-4416  

Bio-Techne

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-technes-rnascope-technology-aids-in-the-retrospective-tissue-diagnosis-of-covid-19-in-cases-with-no-previous-testing-for-sars-cov-2-301346143.html

SOURCE Bio-Techne Corporation

X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com